Modernising and shaping the OvuSense™ fertility monitoring product using mobile app technologies

  • Strategy

    Developing the technical specification and compliance plan

  • App Design

    Creating a modern looking and un-cluttered UI aimed at females looking to conceive

  • App Development

    Building a mobile app with a secure cloud backend that connected to their Class II medical device using NFC

  • Publishing

    Designing the app store assets and publishing the app onto the app stores

Project Description

Fertility Focus chose Genetic Digital as their medical app development partner to help them design and build an app from scratch and integrate it with their Class II medical device.

Their sensor previously worked in conjunction with a dedicated hardware reader and our client saw an opportunity to improve the portability and user friendliness of the product by connecting the sensor to a mobile device. The OvuSense™ App collects fertility related data from the OvuSense™ Sensor that is then displayed on a smartphone or tablet in a user-friendly manner.

Our Solution

OvuSense™ is a unique, real-time ovulation cycle monitoring system.
The sensor is be inserted overnight in the vagina during a woman’s cycle to collect temperature readings.

Sensor data is downloaded to the OvuSense™ App via an NFC interface – the same technology used in contactless payments.

The OvuSense™ App then plots a graph displaying the temperature curve throughout the cycle, and then predicts ovulation up to a day in advance, followed by a confirmation of the exact date of ovulation. We also helped the client in producing the required documentation for regulatory compliance. The OvuSense™ product comprising App and Sensor is CE marked under the Medical Device Directive and FDA listed.

“Genetic Digital was a natural choice for our development project given their previous experience in connecting apps to medical devices.   Together, we’ve delivered a world beating product that makes a real difference to women that are trying to conceive.”

CEO, OvuSense™